Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novametrix Medical Systems, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Wade who wrote (157)	6/24/1999 1:02:00 PM
From: Wink	Read Replies (1) \| Respond to of 207

Yes, I will buy more, but I need fundamental and technical confirmation "together" before I do. Currently the technicals look good but fundamentally speaking we need to see how the earnings play out for the last quarter. Historically it may be late July before they release year end data. I was disappointed with the numbers released in March (thought we were going to beat last year's), so I'm a little hesitant to buy now on the hopes that the last quarter's numbers are good. A nickel a share IMO would be a disaster, but could push the price down to make it attractive (note that I'm a value investor). Will keep my radar up on any developments! ;>)

To: Wade who wrote (157)	6/29/1999 11:50:00 AM
From: Roland Batson	Read Replies (1) \| Respond to of 207

Wade, You do realize that Joe Vincent, NMTX, did borrow the needed $5,000,000 in order to partially fulfill the announced 1.1MM share buyback? The Co is paying commercial rate interest on this money and presently that $5mm is only worth $4.5MM. He also stated at the last Annual Meeting that he "saw no reason" that debt would not be paid back by the end of fiscal 99, Last May 30th. Do you wonder who put him up to this and why, considering there was a 13 Elliot Grp looming and the tax loss selling season around the corner. I recall you having a conversation with Lacourcier in the past. Any recent ones? Would he be willing to do so - to your group of investors? Roland